Heart Disease News and Research

Latest Heart Disease News and Research

Four Los Angeles area hospitals report zero central line infections

Hospitals in Los Angeles vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 41 Los Angeles area hospitals, along with other critical patient safety and satisfaction information for consumers.

2 Feb 2010

RECOTHROM topical hemostat exhibits low rate of anti-product antibody formation

ZymoGenetics, Inc., today announced the publication of pooled safety and immunogenicity observations from eight clinical trials of RECOTHROM in the February issue of the Journal of the American College of Surgeons. The authors concluded that RECOTHROM is a well-tolerated topical hemostatic agent in numerous surgical settings and has a low rate of anti-product antibody formation. In the pooled data from all trials, less than one percent of treated patients developed product-specific antibodies. None of the antibodies neutralized native coagulation proteins.

2 Feb 2010

Minimally invasive living donor liver retrieval for pediatric transplant

NewYork-Presbyterian Morgan Stanley Children's Hospital is the only medical center in the United States to offer minimally invasive liver donation for pediatric transplantation. Surgeons use a laparoscopic technique to remove a section of liver from a living donor for implantation in a pediatric patient -- typically a parent donating to their child. The innovative approach promises dramatically improved recovery for the donor.

2 Feb 2010

ZOLL Medical offers PocketCPR training app for iPhone

ZOLL Medical Corporation today announced that the Company is offering its PocketCPR® training app for iPhone as a free download from the Apple iTunes App Store during February in recognition of the American Heart Association’s American Heart Month.

2 Feb 2010

MEND Program: Effective treatment for pediatric obesity

Ground-breaking results from a study to evaluate the effectiveness of the MEND Program (Mind, Exercise, Nutrition, Do it!), a multi-component community-based childhood obesity intervention (www.mendcentral.org), are published today in the US journal Obesity (www.nature.com/oby/journal/v18/n1s/abs/oby2009433a.html). The results coincide with the launch of Michelle Obama's initiative to reduce childhood obesity announced in the State of the Union speech.

2 Feb 2010

Decreased release of neurotransmitter acetylcholine contributes to heart failure

Scientists at the Robarts Research Institute at The University of Western Ontario, working in collaboration with researchers in Brazil, have used a unique genetically-modified mouse line to reveal a previously unidentified mechanism contributing to heart failure.

2 Feb 2010

Cardiac catheterization: A groundbreaking tool in the field of cardiology

Cardiac catheterizations have been a groundbreaking tool in the field of cardiology. This procedure offers a minimally invasive means for obtaining important information about the heart and its blood vessels, while also providing a less invasive treatment for certain heart conditions.

2 Feb 2010

MDLinx announces new Omnibus offering for international pharmaceutical market research

MDLinx, a division of M3 USA, announced today a new Omnibus offering for international pharmaceutical market research. The new offering, launched at the Pharmaceutical Market Research Conference, enables market researchers a new, simplified, reduced-cost means of accessing specialty physicians around the world.

2 Feb 2010

Findings could lead to new therapeutic strategies for obesity

Peptides that target blood vessels in fat and cause them to go into programmed cell death (termed apoptosis) could become a model for future weight-loss therapies, say University of Cincinnati (UC) researchers.

2 Feb 2010

Cardiac arrest sudden death: The seven warning signs

As Americans look to keep their fitness resolutions and increase their physical activity, Dr. Bing Liem, cardiologist and electrophysiologist at El Camino Hospital in Mountain View, Calif., is hoping to raise awareness of a critical but rare heart condition: congenital malformations of the heart or vascular system, which is to blame for the majority of sudden cardiac deaths in athletes under the age of 40.

2 Feb 2010

Simple genetic test can help in detecting heart abnormalities

Hypertrophic Cardiomyopathy (HCM) is a genetic disease that causes the heart muscle to become abnormally large. It often goes undetected and, as a result, HCM has the dubious distinction of being the leading cause of sudden death in children, young adults and athletes.

2 Feb 2010

ADT can worsen heart risk factors and may increase the risk of heart attack

Androgen-deprivation therapy (ADT), commonly used to treat prostate cancer, can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death, although the relationship between ADT and heart attack or cardiac death has not been definitively established, according to a science advisory published in Circulation: Journal of the American Heart Association and CA: A Cancer Journal for Clinicians.

2 Feb 2010

Smoking cessation increases cardiac health later in life

Smoking affects your cardiac health both before and after a major event like a heart attack. But how much? And does cutting back instead of quitting have a positive effect as well?

2 Feb 2010

Boston Scientific to pay J&J $1.725 billion for settling three patent disputes

Boston Scientific Corporation today announced the settlement of three patent disputes with Johnson & Johnson (J&J). The disputes date back to 2003 and cover Boston Scientific's Jang patent and J&J's Palmaz and Gray patents, all of which involve intellectual property in the cardiovascular arena. Boston Scientific will make a $1.725 billion payment to J&J in connection with the settlement.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

Response Biomedical continues global market expansion, signs Guangzhou Wondfo Biotech in China

Response Biomedical Corporation announced that the Company has signed a second partner, Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China to sell the Company’s diagnostic products, expanding its strategic presence in this important global market.

2 Feb 2010

FDA approves neurostimulation treatment for heart failure

The FDA recently approved the first study of neurostimulation as a treatment for heart failure, a chronic disease that affects nearly six million Americans and is the leading cause of hospitalization in America.

2 Feb 2010

American Diabetes Association announces 2010 schedule for free community health events

In an age of soaring health care costs and staggering diabetes prevalence, the American Diabetes Association announced today its 2010 schedule for free community health events throughout the country -- the American Diabetes Association EXPO.

2 Feb 2010

Congressional leader stresses the importance of annual dilated eye exam for diabetes patients

In recognition of Black History Month, House Majority Whip James E. Clyburn is urging African Americans with diabetes to get an annual diabetic eye exam during February.

1 Feb 2010

Survey finds Americans hesitant to seek mental health for confidentiality reasons

A survey from the American Psychiatric Association has found that workers' fears about losing their status at work and about confidentiality are the reasons American workers hesitate to seek treatment for mental health issues, HealthDay/BusinessWeek reports.

1 Feb 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Four Los Angeles area hospitals report zero central line infections

RECOTHROM topical hemostat exhibits low rate of anti-product antibody formation

Minimally invasive living donor liver retrieval for pediatric transplant

ZOLL Medical offers PocketCPR training app for iPhone

MEND Program: Effective treatment for pediatric obesity

Decreased release of neurotransmitter acetylcholine contributes to heart failure

Cardiac catheterization: A groundbreaking tool in the field of cardiology

MDLinx announces new Omnibus offering for international pharmaceutical market research

Findings could lead to new therapeutic strategies for obesity

Cardiac arrest sudden death: The seven warning signs

Simple genetic test can help in detecting heart abnormalities

ADT can worsen heart risk factors and may increase the risk of heart attack

Smoking cessation increases cardiac health later in life

Boston Scientific to pay J&J $1.725 billion for settling three patent disputes

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

Response Biomedical continues global market expansion, signs Guangzhou Wondfo Biotech in China

FDA approves neurostimulation treatment for heart failure

American Diabetes Association announces 2010 schedule for free community health events

Congressional leader stresses the importance of annual dilated eye exam for diabetes patients

Survey finds Americans hesitant to seek mental health for confidentiality reasons

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in